Results 101 to 110 of about 10,317 (226)

Quality of life and life circumstances in German myasthenia gravis patients [PDF]

open access: yes, 2010
Background Myasthenia gravis (MG) is a chronic neuromuscular disease. Advances in medical therapy have continuously increased the life expectancy of MG patients, without definitively curing the disease.
Sabine Twork   +4 more
core   +2 more sources

Ocular Myasthenia Gravis: Controversies and Updates

open access: yesCurrent Neurology and Neuroscience Reports, 2013
The majority of patients with myasthenia gravis (MG) initially present with ocular symptoms. An unresolved question is whether there are clinical features at onset to guide clinicians to predict an individual patient's conversion risk from ocular MG (OMG) to generalized disease, or "secondary generalized MG" (SGMG), that is, a prognostic model.
Wong, S, Huda, S, Vincent, A, Plant, G
openaire   +3 more sources

Neurological Disorders in Dogs: A Retrospective Analysis of Prevalence, Aetiology, Lesion Locations, and Regional Variations in Northeastern Iran

open access: yesVeterinary Medicine and Science, Volume 12, Issue 3, May 2026.
This retrospective study evaluated 422 dogs with neurological disorders among 9131 canine referrals over 8.5 years in northeastern Iran. Infectious diseases, particularly canine distemper (33.2%), were the leading cause, followed by trauma and idiopathic conditions. The prosencephalon was the most frequently affected anatomical region.
Ali Behrouzian   +2 more
wiley   +1 more source

Frontalis sling procedure for ocular myasthenia gravis

open access: yesClinical Ophthalmology, 2012
Shinichi Asamura1, Hirohiko Kakizaki2, Mitsuhiro Enjyo1, Takahiro Hashimoto1, Noritaka Isogai11Department of Plastic and Reconstructive Surgery, Kinki University School of Medicine, Osakasayama, Osaka, Japan; 2Department of Ophthalmology, Aichi Medical ...
Isogai N   +4 more
doaj  

Study of differential cytokine IFN-γ,IL-10,TGF-β and IL-17 level in patients with myasthenia gravis with antibodies against AChR ,MuSK and LRP4 [PDF]

open access: yes, 2016
目的:通过采用酶联免疫吸附(ELISA)法检测重症肌无力(myastheniagravis,MG)患者血清乙酰胆碱受体抗体(AChR-Ab),肌肉特异性酪氨酸激酶抗体(MuSK-Ab),低密度脂蛋白受体相关蛋白4抗体(LRP4-Ab)浓度,探讨AChR-Ab,MuSK-Ab,LRP4-Ab与重症肌无力临床分型、及与细胞因子干扰素-γ(IFN-γ),白细胞介素-10(IL-10),生长转化因子-β(TGF-β),白细胞介素-17(IL-17)的关系。 方法: 1.本研究分为重症肌无力组和健康对照组 ...
李若冰
core  

Optimal management of Cogan’s syndrome: a multidisciplinary approach [PDF]

open access: yes, 2017
Cogan's syndrome (CS) is a rare disorder characterized by nonsyphilitic interstitial keratitis (IK) and audio-vestibular symptoms. CS affects mainly young Caucasian adults, mostly during their first three decades of age, and may develop into typical and ...
D'Aguanno, Vittorio   +3 more
core   +1 more source

A multimodal diagnostic imaging approach to primary oesophageal squamous cell carcinoma in a dog

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 7‐year‐old male, neutered toy poodle, presented at the Companion Animal Veterinary Teaching Hospital of Utrecht University due to progressive weight loss, dysphagia and regurgitation. Physical and blood examinations revealed a low body condition score and mildly decreased serum folate concentration.
Tannaz Karouei   +4 more
wiley   +1 more source

Congenital muscular dystrophy: from muscle to brain. [PDF]

open access: yes, 2016
Congenital muscular dystrophies (CMDs) are a wide group of muscular disorders that manifest with very early onset of muscular weakness, sometime associated to severe brain involvement.The histologic pattern of muscle anomalies is typical of dystrophic ...
Corsello G   +7 more
core   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis

open access: yesJournal of Ophthalmology, 2014
Aim. To estimate the clinical significance of anti-acetylcholine receptor antibody (anti-AChR-Ab) levels in suspected ocular myasthenia gravis. Methods. In total, 144 patients complaining of fluctuating diplopia and ptosis were evaluated for serum levels
Jung Jin Lee   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy